Prevention

Daniel Diekema, MD, explains how the microbiology lab works to provide optimal drug selection for empiric and directed therapy.

The US Food and Drug Administration (FDA) has cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings.

While a new FDA report shows antibiotic resistance remains low among many food-borne bacteria, some pathogens are increasingly showing multidrug resistance.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

William Schaffner, MD, explains how health care providers can work towards getting patients who are aged 65 and older to receive a flu shot.

While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.

Updated guidance from the CDC on Zika, candidemia infections in patients with C. difficile infections, and more topics made up our Top 5 articles for the month of October 2017.

Daniel Diekema, MD, explains why the microbiology laboratory should be a part of antimicrobial stewardship programs.

Dolutegravir seemed to be a promising maintenance monotherapy for people living with HIV, but the development of resistance mutations in testing strikes it from the list.

James S. Lewis, PharmD, FIDSA, explains why addressing issues surrounding antibiotic use in veterinary medicine is crucial in the fight against antibiotic resistance.

Researchers from The Scripps Research Institute have discovered why egg-based influenza vaccines offer a lower level of protection against H3N2 viruses.

The fast pace of biotechnology and an increasingly globalized world have changed the face of health security.

What is pharma doing about the impending antibiotic resistance “apocalypse?”

Part 3 of our series looks at

Three antimicrobial susceptibility tests have been cleared by the FDA concurrently with the launch of a new antibiotic Baxdela, to help guide its use.

At this year’s annual CHEST meeting, Theravance Biopharma investigators report positive new data pertaining to VIBATIV gleaned from the TOUR study.

Another prong in the battle against resistant Gram-negative infections is the addition of beta-lactamase inhibitors to restore or improve the activity of older carbapenems.

Investigators in China have found that the presence of the MCR-1 gene has increased in humans over a period of 5 years.

Antimicrobial-resistant organisms, particularly Gram-negative bacteria, present a critical threat and a substantial burden.

C. difficile prevention is usually thought of in terms of environmental disinfection and health care worker hand hygiene; what about the patient's role?

In case you missed them, we've compiled the top 5 articles from this past week.

The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.

In a new study, investigators examine the advantages and drawbacks of using metagenomic next-generation sequencing (mNGS) for the identification of pathogens.

A proven marker of host response to bacterial infection may help providers avoid contributing to the rise of antibiotic resistance.

New research is drawing attention to the underlying risk of spreading infectious diseases when participating in organized athletic activities.